celecoxib has been researched along with Lymphoma, T-Cell in 1 studies
Lymphoma, T-Cell: A group of heterogeneous lymphoid tumors representing malignant transformations of T-lymphocytes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Johansson, AS | 1 |
| Pawelzik, SC | 1 |
| Larefalk, A | 1 |
| Jakobsson, PJ | 1 |
| Holmberg, D | 1 |
| Lindskog, M | 1 |
1 other study available for celecoxib and Lymphoma, T-Cell
| Article | Year |
|---|---|
Lymphoblastic T-cell lymphoma in mice is unaffected by Celecoxib as single agent or in combination with cyclophosphamide.
Topics: Administration, Oral; Animals; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemothera | 2009 |